CD# mAb

Related by string. * CD# [002] . CD# [003] . CD# [004] . CD# [001] : CD# monoclonal antibody . CD# ligand . follicular CD# positive . CD4 + CD# . HuMax CD# TM . HuMax CD# R . HuMax CD# . ofatumumab HuMax CD# / MABS . mAbs . MAB . MAbs . Med AB . Mab . MAb : monoclonal antibodies MAbs . WAM MAB . monoclonal antibodies mAbs . Butlers Plc MAB LN . Biosphere MAB . CCR5 mAb . monoclonal antibody IgG1 Mab * *

Related by context. Frequent words. (Click for all words.) 64 Epratuzumab 63 bleomycin 61 TNF α 61 cell lymphomas 61 ependymoma 61 elotuzumab 61 PARP inhibitors 61 cell malignancies 60 lung fibrosis 60 KRAS wild 60 FLT3 60 mycophenolate mofetil 60 hypoxia inducible factor 60 Zolinza 60 myeloproliferative disorders 60 CLL cells 60 lupus nephritis 60 multidrug resistance 60 antitumor 60 iNOS 60 immunomodulator 60 humanized antibody 60 fulvestrant 60 neuroblastoma cells 59 mRCC 59 Traficet EN 59 IGF 1R 59 daptomycin 59 decitabine 59 tyrosine kinase inhibitor 59 EGFR inhibitors 59 lymphopenia 59 IFN gamma 59 cytomegalovirus CMV 59 Carfilzomib 59 xenograft models 59 talabostat 58 superficial bladder cancer 58 glioma cells 58 induces apoptosis 58 induce apoptosis 58 heavily pretreated 58 IGFBP 3 58 von Willebrand disease 58 olmesartan 58 Dasatinib 58 chronic myelogenous leukemia CML 58 PARP inhibitor 58 chronic lymphocytic leukemia CLL 58 Erlotinib 58 Aurora kinase 58 immunodeficiency 58 chlorambucil 58 peripheral blood mononuclear 58 ximelagatran 58 EGF receptor 58 HER2/neu 58 GvHD 58 pertuzumab 58 haematological 57 anticancer therapy 57 malignant transformation 57 GSK# [001] 57 myeloma cells 57 Bortezomib 57 carcinoid 57 breast carcinoma 57 EGFRvIII 57 immunologic diseases 57 breast cancer metastasis 57 malignant pleural mesothelioma 57 heavily pretreated patients 57 indolent NHL 57 neoplastic 57 pheochromocytoma 57 neutralizing antibody 57 HER2 positive metastatic breast 57 Natalizumab 57 allogeneic stem cell 57 nicotinamide 57 tumor lysis syndrome 57 Chronic Lymphocytic Leukemia 57 glioblastoma multiforme GBM 57 Thrombocytopenia 57 myeloid 57 patients evaluable 57 CMV infection 57 cyclosporin 57 Alemtuzumab 57 Trastuzumab 57 febrile neutropenia 57 non Hodgkin lymphomas 57 IL 1beta 56 esophagitis 56 MEK inhibitor 56 Streptococcus pyogenes 56 Rituximab 56 medulloblastomas 56 mycobacterial 56 nilotinib 56 EGFr

Back to home page